QuidelOrtho Corporation (QDEL) vs Rigel Pharmaceuticals, Inc. (RIGL)

A side-by-side comparison of QuidelOrtho Corporation and Rigel Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — QDEL vs RIGL

growth of $100 · dividends reinvested · last 10y
QDEL -43.9% (-5.6%/yr)RIGL +26.8% (+2.4%/yr)RIGL compounded faster over this window
05001kStart $10020182020202220242026$56$127
QDEL RIGL

QDEL vs RIGL: by the numbers

  • •RIGL is the larger company ($860M vs $850M market cap).
  • •RIGL is profitable (116.30% net margin) while QDEL runs a net loss (-39.20%).
  • •RIGL grew revenue faster over the past five years (13.94% vs 7.14% CAGR).

Metrics side by side

Valuation

MetricQDELRIGL
P/E ratioN/A2.85
Forward P/E16.1313.56
P/S ratio0.323.11
P/B ratio0.482.02
EV / EBITDAN/A9.36
FCF yieldN/A9.23%

Profitability

MetricQDELRIGL
Gross margin44.60%91.39%
Operating margin-30.67%42.63%
Net margin-39.20%116.30%
ROE-59.07%75.67%
ROIC-16.05%18.72%

Growth (annualized)

MetricQDELRIGL
Revenue CAGR (5Y)7.14%13.94%
Total return CAGR (5Y)-38.12%6.25%

Frequently asked

Which has grown faster, QDEL or RIGL?
Over the past five years, RIGL grew revenue faster — QDEL at a 7.14% CAGR versus RIGL at 13.94%.
Is QDEL or RIGL more profitable?
RIGL runs the higher net margin — QDEL at -39.20% versus RIGL at 116.30%.
How have QDEL and RIGL total returns compared?
Over the past 10 years, QDEL delivered -5.68% and RIGL delivered 1.77% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.